Clinical Trial Update: Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing doxorubicin/cisplatin/paclitaxel versus carboplatin/paclitaxel in stage III-IV or recurrent endometrial cancer; trial completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: GOG Foundation | Conditions: Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7 | Phase 3 | Status: COMPLETED | Results posted: 2018-04-23